Cibus (CBUS) Set to Announce Quarterly Earnings on Thursday

Cibus (NASDAQ:CBUSGet Free Report) will be posting its quarterly earnings results after the market closes on Thursday, November 7th. Analysts expect Cibus to post earnings of ($0.89) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Cibus (NASDAQ:CBUSGet Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.33). The company had revenue of $0.84 million during the quarter, compared to analysts’ expectations of $0.44 million. Cibus had a negative net margin of 9,856.84% and a negative return on equity of 29.05%. During the same quarter in the previous year, the business posted ($3.05) EPS. On average, analysts expect Cibus to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Cibus Trading Up 1.0 %

NASDAQ:CBUS traded up $0.04 during mid-day trading on Tuesday, hitting $4.20. The stock had a trading volume of 17,956 shares, compared to its average volume of 134,865. Cibus has a twelve month low of $2.86 and a twelve month high of $23.18. The stock has a 50-day simple moving average of $4.27 and a two-hundred day simple moving average of $9.05. The company has a market capitalization of $96.98 million, a PE ratio of -0.26 and a beta of 1.79.

Analyst Ratings Changes

CBUS has been the subject of several recent analyst reports. Canaccord Genuity Group raised shares of Cibus to a “strong-buy” rating in a research report on Friday, July 19th. Alliance Global Partners decreased their price target on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a report on Tuesday, September 24th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $20.00 price objective on shares of Cibus in a report on Tuesday, October 22nd.

View Our Latest Research Report on Cibus

Cibus Company Profile

(Get Free Report)

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

See Also

Earnings History for Cibus (NASDAQ:CBUS)

Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.